Brachytelephalangic chondrodysplasia punctata: prenatal diagnosis and postnatal outcome.

Abstract : We report the prenatal management of a brachytelephalangic chondrodysplasia punctata (CDPX1) case and how postnatal findings confirmed the diagnosis. The mother was initially referred after ultrasound revealed an abnormal fetal mid-face and punctuation of upper femoral epiphyses. Chondrodysplasia punctata (CP) with Binder anomaly was suspected. 3D-HCT revealed brachytelephalangy suggesting CDPX1. At birth, mid-face hypoplasia was marked. Postnatal imaging and genetic analysis confirmed the initial diagnosis. Binder anomaly is probably always associated with CP. The newly revised CP classification facilitates the diagnosis. The main etiologies are metabolic and chromosomal abnormalities, and arylsulfatase E enzyme dysfunction. Thus, screening for arylsulfatase E mutation is mandatory for an accurate diagnosis and can lead to better delineation among CP etiologies associated with a Binder phenotype.
Type de document :
Article dans une revue
Fetal Diagnosis and Therapy, Karger, 2010, 28 (3), pp.186-90. 〈10.1159/000297289〉
Liste complète des métadonnées

Littérature citée [5 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00588105
Contributeur : Nathalie Roux-Buisson <>
Soumis le : mercredi 13 juillet 2011 - 13:22:31
Dernière modification le : jeudi 28 juin 2018 - 09:52:03
Document(s) archivé(s) le : jeudi 30 mars 2017 - 09:49:16

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Citation

Stéphanie Boulet, Klaus Dieterich, Marc Althuser, Frédérique Nugues, Claudia Durand, et al.. Brachytelephalangic chondrodysplasia punctata: prenatal diagnosis and postnatal outcome.. Fetal Diagnosis and Therapy, Karger, 2010, 28 (3), pp.186-90. 〈10.1159/000297289〉. 〈inserm-00588105〉

Partager

Métriques

Consultations de la notice

242